Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels

Detalhes bibliográficos
Autor(a) principal: Castro, Ana Carolina Fernandes Vieira de
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/28433
Resumo: The effect of zinc on neuronal systems is growing interest in scientific research due to a possible role as a modulator of synaptic activity. Additionally, recent research points to the therapeutic potential of zinc oxide nanoparticles (ZnO NPs) on neuronal cells. These nanoparticles are excellent drug carriers to the brain because, besides having positive characteristics for the protection of cellular homeostasis, they are small, allowing them to pass the blood brain barrier and interact directly within these cells. In this sense, the present thesis explored the effect of sub-toxic ZnO NP concentrations on cell viability and ROS production in SH-SY5Y cells, as well as their impact on the expression levels of PSD-95, SHANK 3 and β-actin proteins. The results showed increases in PSD-95 and SHANK 3 protein expression without variations in β-actin expression after neuronal cell exposure to sub-toxic concentrations and at reduced exposure times to ZnO NPs. Future efforts should be implemented to investigate how this increase may reduce brain impairment associated with neurodegenerative diseases. However, the results here presented have clearly identified some of the synaptic molecular targets of ZnO NPs and that these NPs are worthwhile exploring for their therapeutic potential.
id RCAP_7353395f915fa6cf2ee1f598e8ba487c
oai_identifier_str oai:ria.ua.pt:10773/28433
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levelsSynaptic transmissionOxide zinc nanoparticlesNeurodegenerative diseasesSH-SY5Y cellsSHANK 3PSD-95β-actinThe effect of zinc on neuronal systems is growing interest in scientific research due to a possible role as a modulator of synaptic activity. Additionally, recent research points to the therapeutic potential of zinc oxide nanoparticles (ZnO NPs) on neuronal cells. These nanoparticles are excellent drug carriers to the brain because, besides having positive characteristics for the protection of cellular homeostasis, they are small, allowing them to pass the blood brain barrier and interact directly within these cells. In this sense, the present thesis explored the effect of sub-toxic ZnO NP concentrations on cell viability and ROS production in SH-SY5Y cells, as well as their impact on the expression levels of PSD-95, SHANK 3 and β-actin proteins. The results showed increases in PSD-95 and SHANK 3 protein expression without variations in β-actin expression after neuronal cell exposure to sub-toxic concentrations and at reduced exposure times to ZnO NPs. Future efforts should be implemented to investigate how this increase may reduce brain impairment associated with neurodegenerative diseases. However, the results here presented have clearly identified some of the synaptic molecular targets of ZnO NPs and that these NPs are worthwhile exploring for their therapeutic potential.O efeito do zinco nos sistemas neuronais está a aumentar o seu interesse na pesquisa científica devido a um possível papel como modulador da atividade sináptica. Além disso, pesquisas recentes apontam para o potencial terapêutico de nanopartículas de óxido de zinco (ZnO NPs) em células neuronais. Essas nanopartículas são excelentes transportadoras de fármacos para o cérebro porque, além de terem características positivas para a proteção da homeostase celular, são pequenas, permitindo que elas ultrapassem a barreira hematoencefálica e interajam diretamente dentro dessas células. Nesse sentido, a presente tese explorou o efeito de concentrações sub-tóxicas de ZnO NPs na viabilidade celular e produção de ROS em células SH-SY5Y, bem como seu impacto nos níveis de expressão das proteínas PSD-95, SHANK 3 e β-actina. Os resultados mostraram aumentos na expressão das proteínas PSD-95 e SHANK 3, sem variações na expressão da β-actina após a exposição das células neuronais a concentrações sub-tóxicas e em tempos de exposição reduzidos aos ZnO NPs. Esforços futuros devem ser implementados para investigar como esse aumento pode reduzir o comprometimento cerebral associado a doenças neurodegenerativas. No entanto, os resultados aqui apresentados identificaram claramente alguns dos alvos moleculares sinápticos das ZnO NPs e que vale a pena explorar o seu potencial terapêutico.2019-122019-12-01T00:00:00Z2021-12-19T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/28433engCastro, Ana Carolina Fernandes Vieira deinfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T11:55:00Zoai:ria.ua.pt:10773/28433Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:00:58.947524Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels
title Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels
spellingShingle Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels
Castro, Ana Carolina Fernandes Vieira de
Synaptic transmission
Oxide zinc nanoparticles
Neurodegenerative diseases
SH-SY5Y cells
SHANK 3
PSD-95
β-actin
title_short Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels
title_full Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels
title_fullStr Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels
title_full_unstemmed Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels
title_sort Sub-toxic zinc oxide nanoparticles modulate PSD-95 and shank 3 protein levels
author Castro, Ana Carolina Fernandes Vieira de
author_facet Castro, Ana Carolina Fernandes Vieira de
author_role author
dc.contributor.author.fl_str_mv Castro, Ana Carolina Fernandes Vieira de
dc.subject.por.fl_str_mv Synaptic transmission
Oxide zinc nanoparticles
Neurodegenerative diseases
SH-SY5Y cells
SHANK 3
PSD-95
β-actin
topic Synaptic transmission
Oxide zinc nanoparticles
Neurodegenerative diseases
SH-SY5Y cells
SHANK 3
PSD-95
β-actin
description The effect of zinc on neuronal systems is growing interest in scientific research due to a possible role as a modulator of synaptic activity. Additionally, recent research points to the therapeutic potential of zinc oxide nanoparticles (ZnO NPs) on neuronal cells. These nanoparticles are excellent drug carriers to the brain because, besides having positive characteristics for the protection of cellular homeostasis, they are small, allowing them to pass the blood brain barrier and interact directly within these cells. In this sense, the present thesis explored the effect of sub-toxic ZnO NP concentrations on cell viability and ROS production in SH-SY5Y cells, as well as their impact on the expression levels of PSD-95, SHANK 3 and β-actin proteins. The results showed increases in PSD-95 and SHANK 3 protein expression without variations in β-actin expression after neuronal cell exposure to sub-toxic concentrations and at reduced exposure times to ZnO NPs. Future efforts should be implemented to investigate how this increase may reduce brain impairment associated with neurodegenerative diseases. However, the results here presented have clearly identified some of the synaptic molecular targets of ZnO NPs and that these NPs are worthwhile exploring for their therapeutic potential.
publishDate 2019
dc.date.none.fl_str_mv 2019-12
2019-12-01T00:00:00Z
2021-12-19T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/28433
url http://hdl.handle.net/10773/28433
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137665385234432